Health Catalyst (HCAT) Faces Q1 Revenue Decline Expectations Ahead of May 18 Earnings

Health Catalyst (NASDAQ: HCAT) is scheduled to report first-quarter results after the market close on May 18, 2026, with analysts expecting revenue to fall 12.9% from a year earlier. The health care data analytics company reported $74.68 million in revenue in the prior quarter, down 6.2% year over year, while beating Wall Street estimates. However, its revenue and EBITDA guidance for the following quarter came in significantly below analyst expectations. Most analysts have left estimates unchanged over the past 30 days. Health Catalyst shares have risen 49.6% over the past month, outpacing a 26.5% average gain among data analytics peers. The stock recently traded at $1.52, below the average analyst price target of $1.79. Peer results have been mixed in the market reaction. Palantir Technologies posted 84.7% revenue growth and beat estimates by 6.1%, but its shares fell 6.9%. CLEAR Secure reported 19.7% revenue growth and topped estimates by 3.5%, while its stock declined 1.2%.